New DNA SARS-CoV-2 vaccine
The invention relates to combinations, pharmaceutical compositions and kits comprising polynucleotides encoding the spike (S) glycoprotein and the nucleocapsid (N) protein of SARS-CoV-2, either in a single or two separate vectors (e.g., a DNA plasmid), and their use in the prophylactic or therapeutic treatment of COVID-19
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | solicitud de patente biblioteca |
| Language: | English |
| Published: |
2014-02-08
|
| Online Access: | http://hdl.handle.net/10261/368057 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|